Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Emalex Biosciences
330 N. Wabash, Suite 3500
Chicago, IL 60611
Phone: 312-847-1340
https://emalexbiosciences.com/

Emalex Biosciences is a biopharmaceutical company focused on developing treatments for central nervous system movement disorders and fluency disorders with limited or no treatment options. Aligned with its mission, the company is evaluating treatments for childhood-onset fluency disorder(stuttering), and for children and adolescents with Tourette syndrome.

Key Contact
Name
Jeff Aronin
Title
Founder
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
03/23/21 $35,000,000 Series C Fidelity Management & Research Company
Paragon Biosciences
Valor Equity Partners
undisclosed
11/03/22 $250,000,000 Series D Bain Capital Life Sciences
Fidelity Management & Research Company
Paragon Biosciences
Valor Equity Partners
undisclosed